HPV jabs will not be 'cost-effective' for boys

Cervical cancer US study finds that high uptake among girls eliminates the case for vaccinating boys as well.

HPV jabs for boys would not be cost-effective if there is a high enough uptake among girls, say US researchers.

Latest figures from the NHS Information Centre show that 70 per cent of eligible 12- to 13-year-old girls received all three doses, and 87 per cent one dose, in 2008/9.

Future uptake levels could be hit after a 14-year old Coventry girl died shortly after receiving an HPV jab at school last month, although a post-mortem later found her death was caused by a malignant tumour.

Earlier this year, experts warned that the DoH may be forced to add boys to the HPV vaccination programme to hit the uptake levels required for herd immunity (GP, 3 April).

For this study, researchers from Harvard University in Boston conducted a cost-effectiveness analysis to compare HPV vaccination of pre-adolescent girls alone with vaccination of both girls and boys.

They used NICE's preferred cost-effectiveness benchmark - cost per 'quality adjusted life year' (QALY). Vaccination was considered to be value for money if it cost between £31,172 and £62,344 per extra QALY.

Overall, they found that while the vaccination of 12-year-old girls was cost-effective, including boys in the vaccination programme surpassed the upper QALY threshold.

The researchers concluded: 'Our results suggest that if vaccine coverage and efficacy are high among pre-adolescent girls, including boys in an HPV programme is unlikely to provide comparatively good value for resources.'

 

GP Online recommends

BMJ Online 2009

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

The proportion of NHS GPs trained in the EEA has stabilised after a steady decline...

GPs split on calls to suspend appraisal for duration of pandemic

GPs split on calls to suspend appraisal for duration of pandemic

Senior GPs are divided over calls for appraisal to be halted for the rest of the...

GP fears rising over covert recording of consultations in pandemic

GP fears rising over covert recording of consultations in pandemic

Fears over patients covertly recording consultations have increased among GPs since...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...